在非小细胞肺癌中,Plin2通过激活AKT/mTOR通路来抑制自
Yawei Wang1, Ye Hu2, Rongjian Xu1
1Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, No.16 of Jiangsu Road, Qingdao, 266000, China.
Experimental cell research
|February 1, 2024
概括
利平2 (Plin2) 通过增加细胞增殖和通过AKT/mTOR通路抑制自,促进非小细胞肺癌 (NSCLC) 的进展. 较高的Plin2表达与较大的瘤和较差的NSCLC预后相关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 利平2 (Plin2) 涉及到人类各种癌症.
- 异常的Plin2表达与非小细胞肺癌 (NSCLC) 的预后不佳有关.
- 在NSCLC中Plin2的确切作用和机制尚未完全阐明.
研究的目的:
- 调查Perilipin 2 (Plin2) 在非小细胞肺癌 (NSCLC) 进展中的特定作用.
- 阐明Plin2影响NSCLC的潜在分子机制.
主要方法:
- 在NSCLC组织中分析Plin2表达.
- 在体外研究评估Plin2对NSCLC细胞增殖和自的作用.
- 对AKT/mTOR通路激活的研究.
- 在裸体小鼠中进行体内瘤生成测试.
主要成果:
- 在NSCLC组织中发现Plin2表达率较低.
- 较高的Plin2表达与较大的瘤大小和较差的预后有关.
- 通过激活AKT/mTOR通路,Plin2促进了NSCLC细胞的增殖,并抑制了自.
- 对AKT酸化的调节逆转了Plin2.2的影响.
- 在体内,Plin2增强了皮下瘤的形成.
结论:
- 在NSCLC的进展中,Plin2起着致癌作用.
- 在NSCLC中,Plin2通过AKT/mTOR途径促进增殖并抑制自.
- Plin2代表了NSCLC治疗的潜在治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


